T-cell lymphomas, version 2.2018: Featured updates to the NCCN Guidelines Journal Article
| Authors: | Horwitz, S. M.; Ansell, S. M.; Ai, W. Z.; Barnes, J.; Barta, S. K.; Choi, M.; Clemens, M. W.; Dogan, A.; Greer, J. P.; Halwani, A.; Bradley, M. H.; Hoppe, R. T.; Jacobsen, E.; Jagadeesh, D.; Kim, Y. H.; Lunning, M. A.; Mehta, A.; Mehta-Shah, N.; Oki, Y.; Olsen, E. A.; Pro, B.; Rajguru, S. A.; Shanbhag, S.; Shustov, A.; Sokol, L.; Torka, P.; Wilcox, R.; William, B.; Zain, J.; Dwyer, M. A.; Sundar, H. |
| Article Title: | T-cell lymphomas, version 2.2018: Featured updates to the NCCN Guidelines |
| Abstract: | Natural killer (NK)/T-cell lymphomas are a rare and distinct subtype of non-Hodgkin's lymphomas. NK/T-cell lymphomas are predominantly extranodal and most of these are nasal type, often localized to the upper aerodigestive tract. Because extranodal NK/T-cell lymphomas (ENKL) are rare malignancies, randomized trials comparing different regimens have not been conducted to date and standard therapy has not yet been established for these patients. These NCCN Guidelines Insights discuss the recommendations for the diagnosis and management of patients with ENKL as outlined in the NCCN Guidelines for T-Cell Lymphomas. © JNCCN-Journal of the National Comprehensive Cancer Network. |
| Keywords: | cancer chemotherapy; treatment response; review; cancer radiotherapy; antineoplastic agent; cancer diagnosis; practice guideline; hematopoietic stem cell transplantation; chemoradiotherapy; induction chemotherapy; nk t cell lymphoma; human |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 16 |
| Issue: | 2 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2018-02-01 |
| Start Page: | 123 |
| End Page: | 135 |
| Language: | English |
| DOI: | 10.6004/jnccn.2018.0007 |
| PROVIDER: | scopus |
| PUBMED: | 29439173 |
| DOI/URL: | |
| Notes: | Review -- Export Date: 1 March 2018 -- Source: Scopus |
